Iovance Biotherapeutics Inc (IOVA)
Equity Ratio
80.40%
Quarterly · Period ending:
IOVA Equity Ratio
Latest reported80.40%period ending
Latest reported80.40%period ending
IOVA Quarterly Equity Ratio (94.92% → 80.40%)
Latest values, visible window
High-resolution chart · PNG
IOVA equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 80.3954% | |
| 77.9714% | |
| 76.5009% | |
| 77.6052% | |
| 76.9737% | |
| 79.4283% | |
| 78.03% | |
| 78.0389% | |
| 79.6974% | |
| 78.179% | |
| 74.9167% | |
| 79.0797% | |
| 76.3996% | |
| 80.8569% | |
| 75.2487% | |
| 72.1229% | |
| 77.3788% | |
| 78.7153% | |
| 79.9733% | |
| 84.2554% | |
| 87.2915% | |
| 86.2582% | |
| 85.4306% | |
| 90.9941% | |
| 92.7519% | |
| 84.3964% | |
| 86.745% | |
| 89.7199% | |
| 91.1677% | |
| 94.2427% | |
| 96.9577% | |
| 93.8435% | |
| 95.0195% | |
| 95.2188% | |
| 93.6334% | |
| 95.0974% | |
| 93.5803% | |
| 96.4586% | |
| 97.1097% | |
| 98.2482% | |
| 97.6202% | |
| 98.1839% | |
| 98.4572% | |
| 97.456% | |
| 98.3735% | |
| 98.3171% | |
| 96.4268% | |
| 92.7732% | |
| 93.7607% | |
| 92.9405% | |
| 88.5782% | |
| -1,980.9869% | |
| -463.6264% | |
| -43,336.8122% | |
| -38,484.602% | |
| -57,791.7224% | |
| -25,328.6217% | |
| -22,458.1975% | |
| -2,248.4594% | |
| -165.4956% | |
| -301.1685% | |
| 17.1028% | |
| 43.676% | |
| 43.9127% | |
| 96.3625% | |
| 93.4386% | |
| -140.0332% | |
| -449.8587% | |
| -229.2501% | |
| -109.792% | |
| 40.6985% | |
| 83.9834% | |
| 90.4324% | |
| 94.916% |